Glycemic index, glycemic load, and risk of coronary heart disease: a pan-European cohort study.


Journal

The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 10 10 2019
accepted: 27 05 2020
pubmed: 4 7 2020
medline: 26 9 2020
entrez: 4 7 2020
Statut: ppublish

Résumé

High carbohydrate intake raises blood triglycerides, glucose, and insulin; reduces HDLs; and may increase risk of coronary heart disease (CHD). Epidemiological studies indicate that high dietary glycemic index (GI) and glycemic load (GL) are associated with increased CHD risk. The aim of this study was to determine whether dietary GI, GL, and available carbohydrates are associated with CHD risk in both sexes. This large prospective study-the European Prospective Investigation into Cancer and Nutrition-consisted of 338,325 participants who completed a dietary questionnaire. HRs with 95% CIs for a CHD event, in relation to intake of GI, GL, and carbohydrates, were estimated using covariate-adjusted Cox proportional hazard models. After 12.8 y (median), 6378 participants had experienced a CHD event. High GL was associated with greater CHD risk [HR 1.16 (95% CI: 1.02, 1.31) highest vs. lowest quintile, p-trend 0.035; HR 1.18 (95% CI: 1.07, 1.29) per 50 g/day of GL intake]. The association between GL and CHD risk was evident in subjects with BMI (in kg/m2) ≥25 [HR: 1.22 (95% CI: 1.11, 1.35) per 50 g/d] but not in those with BMI <25 [HR: 1.09 (95% CI: 0.98, 1.22) per 50 g/d) (P-interaction = 0.022). The GL-CHD association did not differ between men [HR: 1.19 (95% CI: 1.08, 1.30) per 50 g/d] and women [HR: 1.22 (95% CI: 1.07, 1.40) per 50 g/d] (test for interaction not significant). GI was associated with CHD risk only in the continuous model [HR: 1.04 (95% CI: 1.00, 1.08) per 5 units/d]. High available carbohydrate was associated with greater CHD risk [HR: 1.11 (95% CI: 1.03, 1.18) per 50 g/d]. High sugar intake was associated with greater CHD risk [HR: 1.09 (95% CI: 1.02, 1.17) per 50 g/d]. This large pan-European study provides robust additional support for the hypothesis that a diet that induces a high glucose response is associated with greater CHD risk.

Sections du résumé

BACKGROUND
High carbohydrate intake raises blood triglycerides, glucose, and insulin; reduces HDLs; and may increase risk of coronary heart disease (CHD). Epidemiological studies indicate that high dietary glycemic index (GI) and glycemic load (GL) are associated with increased CHD risk.
OBJECTIVES
The aim of this study was to determine whether dietary GI, GL, and available carbohydrates are associated with CHD risk in both sexes.
METHODS
This large prospective study-the European Prospective Investigation into Cancer and Nutrition-consisted of 338,325 participants who completed a dietary questionnaire. HRs with 95% CIs for a CHD event, in relation to intake of GI, GL, and carbohydrates, were estimated using covariate-adjusted Cox proportional hazard models.
RESULTS
After 12.8 y (median), 6378 participants had experienced a CHD event. High GL was associated with greater CHD risk [HR 1.16 (95% CI: 1.02, 1.31) highest vs. lowest quintile, p-trend 0.035; HR 1.18 (95% CI: 1.07, 1.29) per 50 g/day of GL intake]. The association between GL and CHD risk was evident in subjects with BMI (in kg/m2) ≥25 [HR: 1.22 (95% CI: 1.11, 1.35) per 50 g/d] but not in those with BMI <25 [HR: 1.09 (95% CI: 0.98, 1.22) per 50 g/d) (P-interaction = 0.022). The GL-CHD association did not differ between men [HR: 1.19 (95% CI: 1.08, 1.30) per 50 g/d] and women [HR: 1.22 (95% CI: 1.07, 1.40) per 50 g/d] (test for interaction not significant). GI was associated with CHD risk only in the continuous model [HR: 1.04 (95% CI: 1.00, 1.08) per 5 units/d]. High available carbohydrate was associated with greater CHD risk [HR: 1.11 (95% CI: 1.03, 1.18) per 50 g/d]. High sugar intake was associated with greater CHD risk [HR: 1.09 (95% CI: 1.02, 1.17) per 50 g/d].
CONCLUSIONS
This large pan-European study provides robust additional support for the hypothesis that a diet that induces a high glucose response is associated with greater CHD risk.

Identifiants

pubmed: 32619242
pii: S0002-9165(22)00836-X
doi: 10.1093/ajcn/nqaa157
pmc: PMC7458777
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

631-643

Subventions

Organisme : Medical Research Council
ID : MR/L003120/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00006/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/13/13/30194
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/09/002
Pays : United Kingdom
Organisme : European Research Council
ID : 268834
Pays : International
Organisme : Medical Research Council
ID : G0800270
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00006/3
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG13/13/30194
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/08/014
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/5
Pays : United Kingdom

Informations de copyright

Copyright © The Author(s) on behalf of the American Society for Nutrition 2020.

Références

Atherosclerosis. 2014 May;234(1):11-6
pubmed: 24583500
Curr Atheroscler Rep. 2005 Nov;7(6):455-9
pubmed: 16256003
Am J Epidemiol. 2007 Oct 15;166(8):912-23
pubmed: 17670911
Eur J Clin Nutr. 2007 Sep;61(9):1037-56
pubmed: 17375121
Int J Epidemiol. 1997;26 Suppl 1:S6-14
pubmed: 9126529
Am J Clin Nutr. 2006 Jun;83(6):1306-12
pubmed: 16762941
Am J Epidemiol. 2018 Oct 1;187(10):2126-2135
pubmed: 29868784
Am J Epidemiol. 1986 Jul;124(1):17-27
pubmed: 3521261
N Engl J Med. 2006 Nov 9;355(19):1991-2002
pubmed: 17093250
Am J Clin Nutr. 2001 Mar;73(3):560-6
pubmed: 11237932
Cochrane Database Syst Rev. 2017 Jul 31;7:CD004467
pubmed: 28759107
Am J Clin Nutr. 2007 Jun;85(6):1521-6
pubmed: 17556687
JAMA. 2002 May 8;287(18):2414-23
pubmed: 11988062
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
pubmed: 10993420
Am J Clin Nutr. 2002 Jul;76(1):274S-80S
pubmed: 12081851
Am J Clin Nutr. 2014 Jul;100(1):65-79
pubmed: 24808490
J Am Coll Nutr. 2010 Feb;29(1):65-71
pubmed: 20595647
Am J Cardiol. 2012 Jun 1;109(11):1608-13
pubmed: 22440121
Lancet. 2019 Feb 2;393(10170):434-445
pubmed: 30638909
J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32
pubmed: 20863953
Am J Clin Nutr. 2010 Jun;91(6):1764-8
pubmed: 20375186
Curr Atheroscler Rep. 2014 Jan;16(1):381
pubmed: 24271882
Am J Clin Nutr. 2002 Jul;76(1):5-56
pubmed: 12081815
J Am Coll Cardiol. 2007 Jul 3;50(1):14-21
pubmed: 17601539
J Am Heart Assoc. 2012 Oct;1(5):e000752
pubmed: 23316283
Am J Clin Nutr. 2003 Oct;78(4):850S-857S
pubmed: 14522749
Nutr Metab Cardiovasc Dis. 2011 Feb;21(2):144-9
pubmed: 19836217
Am J Clin Nutr. 2000 Jun;71(6):1455-61
pubmed: 10837285
Ann Epidemiol. 2010 Aug;20(8):610-6
pubmed: 20609341
J Am Coll Cardiol. 2015 Oct 6;66(14):1538-1548
pubmed: 26429077
Blood Press Monit. 2002 Apr;7(2):95-104
pubmed: 12048426
Diabetologia. 2011 Sep;54(9):2272-82
pubmed: 21717116
Am J Clin Nutr. 2017 Jul;106(1):35-43
pubmed: 28515068
Br J Nutr. 2013 Nov 14;110(9):1704-11
pubmed: 23534456
JAMA. 2008 Dec 17;300(23):2742-53
pubmed: 19088352
Crit Rev Food Sci Nutr. 2003;43(4):357-77
pubmed: 12940416
Br J Nutr. 2005 Dec;94(6):922-30
pubmed: 16351769
Lancet. 2017 Nov 4;390(10107):2050-2062
pubmed: 28864332
Arch Intern Med. 2006 Feb 13;166(3):285-93
pubmed: 16476868
Nutr Metab Cardiovasc Dis. 2013 Jan;23(1):1-10
pubmed: 22841185
Nutr Metab Cardiovasc Dis. 2014 Apr;24(4):337-43
pubmed: 24613757
Circulation. 2017 Jul 18;136(3):e1-e23
pubmed: 28620111
Am J Clin Nutr. 2000 Feb;71(2):412-33
pubmed: 10648253
Mayo Clin Proc Innov Qual Outcomes. 2019 Feb 26;3(1):52-69
pubmed: 30899909
PLoS One. 2012;7(12):e52182
pubmed: 23284926
Eur J Epidemiol. 2007;22(2):129-41
pubmed: 17295097
Am J Clin Nutr. 2002 Jul;76(1):290S-8S
pubmed: 12081854
Am J Clin Nutr. 1981 Mar;34(3):362-6
pubmed: 6259925
Am J Epidemiol. 2013 Nov 15;178(10):1542-9
pubmed: 24008907
BMJ. 2007 Nov 3;335(7626):914-6
pubmed: 17974687
Mayo Clin Proc. 2019 Dec;94(12):2399-2414
pubmed: 31806098

Auteurs

Sabina Sieri (S)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Claudia Agnoli (C)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Sara Grioni (S)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Elisabete Weiderpass (E)

International Agency for Research on Cancer, WHO, Lyon, France.

Amalia Mattiello (A)

Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

Ivonne Sluijs (I)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

Maria Jose Sanchez (MJ)

Andalusian School of Public Health, Granada, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain.
Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.

Marianne Uhre Jakobsen (MU)

National Food Institute, Division for Diet, Disease Prevention, and Toxicology, Technical University of Denmark, Kongens Lyngby, Denmark.

Michael Sweeting (M)

MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Department of Health Sciences, University of Leicester, Leicester, United Kingdom.

Yvonne T van der Schouw (YT)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

Lena Maria Nilsson (LM)

Department of Public Health and Clinical Medicine, Sustainable Health, Umeå University, Umeå, Sweden.

Patrik Wennberg (P)

Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, Umeå, Sweden.

Verena A Katzke (VA)

Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.

Tilman Kühn (T)

Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.

Kim Overvad (K)

Department of Public Health, Aarhus University, Aarhus, Denmark.

Tammy Y N Tong (TYN)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

Moreno-Iribas Conchi (MI)

Public Health Institute of Navarra, IdiSNA, Pamplona, Spain.

José Ramón Quirós (JR)

Public Health Directorate, Asturias, Spain.

Juan Manuel García-Torrecillas (JM)

Hospital Universitario Torrecárdenas, Almería, Spain.

Olatz Mokoroa (O)

Public Health Division of Gipuzkoa, BioDonostia Research Institute, San Sebastian, Spain.

Jesús-Humberto Gómez (JH)

Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.

Anne Tjønneland (A)

Diet, Genes, and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Emiliy Sonestedt (E)

Nutritional Epidemiology, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.

Antonia Trichopoulou (A)

Hellenic Health Foundation, Athens, Greece.

Anna Karakatsani (A)

Hellenic Health Foundation, Athens, Greece.
2nd Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, "ATTIKON" University Hospital, Haidari, Greece.

Elissavet Valanou (E)

Hellenic Health Foundation, Athens, Greece.

Jolanda M A Boer (JMA)

National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

W M Monique Verschuren (WMM)

National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Marie-Christine Boutron-Ruault (MC)

Center for Research in Epidemiology and Population Health, University Paris-South, Faculty of Medicine, University Versailles-St Quentin, National Institute for Health and Medical Research, Université Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.

Guy Fagherazzi (G)

Center for Research in Epidemiology and Population Health, University Paris-South, Faculty of Medicine, University Versailles-St Quentin, National Institute for Health and Medical Research, Université Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.

Anne-Laure Madika (AL)

Center for Research in Epidemiology and Population Health, University Paris-South, Faculty of Medicine, University Versailles-St Quentin, National Institute for Health and Medical Research, Université Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.
Université Lille, CHU Lille, Lille, France.

Manuela M Bergmann (MM)

Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.
DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin, Germany.
University of Potsdam, Institute of Nutritional Sciences, Nuthetal, Germany.

Pietro Ferrari (P)

International Agency for Research on Cancer, WHO, Lyon, France.

Heinz Freisling (H)

International Agency for Research on Cancer, WHO, Lyon, France.

Hannah Lennon (H)

International Agency for Research on Cancer, WHO, Lyon, France.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention, Turin, Italy.

Giovanna Masala (G)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, Florence, Italy.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, "Civic-M.P.Arezzo" Hospital, ASP Ragusa, Ragusa, Italy.

Elio Riboli (E)

Department of Epidemiology and Public Health, Imperial College London, London, United Kingdom.

Nicholas J Wareham (NJ)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.

John Danesh (J)

MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Nita G Forouhi (NG)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.

Adam S Butterworth (AS)

MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Vittorio Krogh (V)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH